The WACC of Sangamo Therapeutics Inc (SGMO) is 8.3%.
| Range | Selected | |
| Cost of equity | 8.30% - 14.90% | 11.60% |
| Tax rate | 0.20% - 0.20% | 0.20% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 6.6% - 10.0% | 8.3% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.96 | 1.8 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 8.30% | 14.90% |
| Tax rate | 0.20% | 0.20% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 6.6% | 10.0% |
| Selected WACC | 8.3% | |